Hillevax

2 followers


HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infecti... Read more

Industries

Employees

11-50

Links

Org chart

Rob Hershberg
CEO, President & Chair

Rob Hershberg

Collapse
Shane Maltbie
Chief Financial Officer
Astrid Borkowski
Chief Medical Officer
Paul Bavier
General Counsel, Secretary & Chief Administrative Officer
Tomoe Felder
Director, Strategy And Operations, Chief Medical Office
Ozzie Berger
Senior Vice President
Christopher Aakre, PhD
Vice President, Program Management
Holger Koch
VP Analytical Research & Development
Tara Raab
Vice President Of Quality
Anju Chatterji
Chief Technology Officer
Pankaj Bavaskar
Associate Director Supply Chain And Procurement